Abe H, Semba H, Takeda N (2017) The roles of hypoxia signaling in the pathogenesis of cardiovascular diseases. J Atheroscler Thromb 24:884–894

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ahmad S, Panda BP, Kohli K, Fahim M, Dubey K (2017) Folic acid ameliorates celecoxib cardiotoxicity in a doxorubicin heart failure rat model. Pharm Biol 55:1295–1303

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brusselmans K, Compernolle V, Tjwa M, Wiesener MS, Maxwell PH, Collen D, Carmeliet P (2003) Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia. J Clin Invest 111:1519–1527

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen T, Wang R, Jiang W, Wang H, Xu A, Lu G, Ren Y, Xu Y, Song Y, Yong S, Ji H, Ma Z (2016) Protective effect of Astragaloside IV against paraquat-induced lung injury in mice by suppressing Rho signaling. Inflammation 39:483–492

Article  CAS  PubMed  Google Scholar 

Christopoulou E, Liamis G, Naka K, Touloupis P, Gkartzonikas I, Florentin M (2022) Hyponatremia in patients with heart failure beyond the neurohormonal activation associated with reduced cardiac output: a holistic approach. Cardiology 147:507–520

Article  CAS  PubMed  Google Scholar 

Dong Z, Zhou J, Zhang Y, Chen Y, Yang Z, Huang G, Chen Y, Yuan Z, Peng Y, Cao T (2017) Astragaloside-IV alleviates heat-induced inflammation by inhibiting endoplasmic reticulum stress and autophagy. Cell Physiol Biochem 42:824–837

Article  CAS  PubMed  Google Scholar 

Feng M, Li Z, Wang D, Wang F, Wang C, Wang C, Ding F (2018) Microrna-210 aggravates hypoxia-induced injury in cardiomyocyte H9c2 cells by targeting CXCR4. Biomed Pharmacother 102:981–987

Article  CAS  PubMed  Google Scholar 

Fioretto P, Mauer M (2007) Histopathology of diabetic nephropathy. Semin Nephrol 27:195–207

Article  PubMed  PubMed Central  Google Scholar 

Forzano I, Wilson S, Lombardi A, Jankauskas SS, Kansakar U, Mone P, Varzideh F, Santulli G (2023) SGLT2 inhibitors: an evidence-based update on cardiovascular implications. Expert Opin Investig Drugs 32:839–847

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gong L, Chang H, Zhang J, Guo G, Shi J, Xu H (2018) Astragaloside IV protects rat cardiomyocytes from hypoxia-induced injury by down-regulation of miR-23a and miR-92a. Cell Physiol Biochem 49:2240–2253

Article  CAS  PubMed  Google Scholar 

Guo Z, Tian Y, Gao J, Zhou B, Zhou X, Chang X, Zhou H (2024) Enhancement of mitochondrial homeostasis: a novel approach to attenuate hypoxic myocardial injury. Int J Med Sci 21:2897–2911

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heck-Swain KL, Koeppen M (2023) The intriguing role of Hypoxia-Inducible factor in myocardial ischemia and reperfusion: A comprehensive review. J Cardiovasc Dev Disease 10:215

Article  CAS  Google Scholar 

Koeppen M, Lee JW, Seo SW, Brodsky KS, Kreth S, Yang IV, Buttrick PM, Eckle T, Eltzschig HK (2018) Hypoxia-inducible factor 2-alpha-dependent induction of Amphiregulin dampens myocardial ischemia-reperfusion injury. Nat Commun 9:816

Article  PubMed  PubMed Central  Google Scholar 

Li L, Hou X, Xu R, Liu C, Tu M (2017) Research review on the pharmacological effects of Astragaloside IV. Fundam Clin Pharmacol 31:17–36

Article  CAS  PubMed  Google Scholar 

Li B, Yu J, Liu P, Zeng T, Zeng X (2021) Astragaloside IV protects cardiomyocytes against hypoxia injury via HIF-1α and the JAK2/STAT3 pathway. Annals Translational Med 9:1435

Article  CAS  Google Scholar 

Li X, Liang J, Qin A, Wang T, Liu S, Li W, Yuan C, Qu L, Zou W (2022) Protective effect of di’ao Xinxuekang capsule against doxorubicin-induced chronic cardiotoxicity. J Ethnopharmacol 287:114943

Article  CAS  PubMed  Google Scholar 

Lian Y, Wang J, Feng J, Ding J, Ma Z, Li J, Peng P, De W, Wang K (2016) Long non-coding RNA IRAIN suppresses apoptosis and promotes proliferation by binding to LSD1 and EZH2 in pancreatic cancer. Tumour Biology: J Int Soc Oncodevelopmental Biology Med 37:14929–14937

Article  CAS  Google Scholar 

Liu ZH, Liu HB, Wang J (2018) Astragaloside IV protects against the pathological cardiac hypertrophy in mice. Biomed Pharmacother 97:1468–1478

Article  CAS  PubMed  Google Scholar 

Marti HP, Pavía López AA, Schwartzmann P (2024) Safety and tolerability of β-blockers: importance of cardioselectivity. Curr Med Res Opin 40:55–62

Article  CAS  PubMed  Google Scholar 

Ren S, Zhang H, Mu Y, Sun M, Liu P (2013) Pharmacological effects of Astragaloside IV: a literature review. J Tradit Chin Med 33:413–416

Article  PubMed  Google Scholar 

Schram K, Ganguly R, No EK, Fang X, Thong FS, Sweeney G (2011) Regulation of MT1-MMP and MMP-2 by leptin in cardiac fibroblasts involves Rho/ROCK-dependent actin cytoskeletal reorganization and leads to enhanced cell migration. Endocrinology 152:2037–2047

Article  CAS  PubMed  Google Scholar 

Shangzu Z, Qiyang L, Sichao D, Yutong W, Yangyang L, Yan C, Gengqiang Y, Ting Z, Zhiming M, Fuxian L, Liying Z, Yongqi L (2024) The impact of X-rays on cardiac hydrometabolism and the regulatory role of AS-IV. Int Immunopharmacol 143:113533

Article  PubMed  Google Scholar 

Sharma NM, Cunningham CJ, Zheng H, Liu X, Patel KP (2016) Hypoxia-inducible factor-1α mediates increased sympathoexcitation via glutamatergic N-methyl-d-aspartate receptors in the paraventricular nucleus of rats with chronic heart failure. Circulation: Heart Failure 9:e003423

CAS  PubMed  Google Scholar 

Song MT, Ruan J, Zhang RY, Deng J, Ma ZQ, Ma SP (2018) Astragaloside IV ameliorates neuroinflammation-induced depressive-like behaviors in mice via the PPARgamma/NF-kappaB/NLRP3 inflammasome axis. Acta Pharmacol Sin 39:1559–1570

Article  CAS  PubMed  PubMed Central  Google Scholar 

Su HF, Shaker S, Kuang Y, Zhang M, Ye M, Qiao X (2021) Phytochemistry and cardiovascular protective effects of Huang-qi (Astragali radix). Med Res Rev 41:1999–2038

Article  PubMed  Google Scholar 

Sun L, Huang N, Yang C, Feng J, Chen H, Feng W, Gao Z, Wang B, Wang J (2025) Hirudin-Based treatment of Diabetes-Induced erectile dysfunction through inhibition of the HIF-1α to regulate rhoa/rock signaling pathway: an in vivo animal experiment. Am J Men’s Health 19:15579883241310763

Article  Google Scholar 

Tang D, Gu Y, Chen S, Niu T, Zhu J, Liu P, Ding M, Guo Y (2024) Alpha-ketoglutarate is required for chronic hypoxia-induced cardiac remodeling. Am J Physiol Cell Physiol 327:C728–c36

Article  CAS  PubMed  Google Scholar 

Tian H, Lu J, He H, Zhang L, Dong Y, Yao H, Feng W, Wang S (2016) The effect of astragalus as an adjuvant treatment in type 2 diabetes mellitus: A (preliminary) meta-analysis. J Ethnopharmacol 191:206–215

Article  PubMed  Google Scholar 

Ullah K, Ai L, Li Y, Liu L, Zhang Q, Pan K, Humayun Z, Piao L, Sitikov A, Zhao Q, Su Q, Sharp W, Fang Y, Wu D, Liao JK, Wu R (2025) ARNT-dependent HIF-2α signaling protects cardiac microvascular barrier integrity and heart function post-myocardial infarction. Commun Biology 8:440

Article  CAS  Google Scholar 

Voors AA, Kremer D, Geven C, Ter Maaten JM, Struck J, Bergmann A, Pickkers P, Metra M, Mebazaa A, Düngen HD, Butler J (2019) Adrenomedullin in heart failure: pathophysiology and therapeutic application. Eur J Heart Fail 21:163–171

Article  CAS  PubMed  Google Scholar 

Wang HL, Zhou QH, Xu MB, Zhou XL, Zheng GQ (2017) Astragaloside IV for Experimental Focal Cerebral Ischemia: Preclinical Evidence and Possible Mechanisms. Oxid Med Cell Longev 2017:8424326

Article  PubMed  PubMed Central